Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Indaba Capital Management, L.P.

Q1 2025 · 13F-HR

Indaba Capital Management, L.P.holdings as filed

Filed 2025-05-15 · accession 0001011438-25-000318

$166.6M
Reported value
12
Positions
2025-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
05988JAD5BAND 0.5 04/01/28BANDWIDTH INC$32.5M19.5%40,250,000CommonSOLE
866082AA8INN 1.5 02/15/26SUMMIT HOTEL PPTYS$27.8M16.7%29,039,000CommonSOLE
68339B104ONTFON24 INC$22.0M13.2%4,240,256CommonSOLE
00430HAC6ACCELERATE DIAGNOSTICS INC$18.5M11.1%37,049,299CommonSOLE
46333XAH1IRWD 1.5 06/15/26IRONWOOD PHARMACEUTICALS INC$15.1M9.05%17,000,000CommonSOLE
294628102HP5AEQUITY COMWLTH$13.5M8.12%8,403,411CommonSOLE
761299AB2TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC$12.8M7.67%13,000,000CommonSOLE
09227Q100BLKBBLACKBAUD INC$12.0M7.19%193,000CommonSOLE
29664W105ESPRESPERION THERAPEUTICS INC NE$4.3M2.59%3,000,000CommonSOLE
047726302BATRKATLANTA BRAVES HLDGS INC$3.8M2.25%93,811CommonSOLE
29082K105EMBCEMBECTA CORP$2.8M1.70%221,938CommonSOLE
00791N102ADVANTAGE SOLUTIONS INC$1.5M0.89%980,865CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.